Page last updated: 2024-08-25

rosiglitazone and chrysin

rosiglitazone has been researched along with chrysin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX1
Deng, HW; Hu, CP; Li, YJ; Peng, SM; Tan, LF; Zou, XQ1
Doddareddy, MR; Gavande, N; Groundwater, PW; Hibbs, DE; Matin, A; Nammi, S; Roubin, RH1
Liang, YC; Lin, JK; Lin-Shiau, SY; Tsai, DC; Tsai, SH1

Other Studies

4 other study(ies) available for rosiglitazone and chrysin

ArticleYear
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
    Journal of medicinal chemistry, 2009, Nov-12, Volume: 52, Issue:21

    Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship

2009
Furoxan nitric oxide donor coupled chrysin derivatives: synthesis and vasculoprotection.
    Bioorganic & medicinal chemistry letters, 2011, Feb-15, Volume: 21, Issue:4

    Topics: Aldehyde Reductase; Cysteine; Flavonoids; Glycation End Products, Advanced; Hep G2 Cells; Humans; Nitric Oxide; Oxadiazoles; Vascular Diseases

2011
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.
    Bioorganic & medicinal chemistry, 2013, Feb-01, Volume: 21, Issue:3

    Topics: Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Isoflavones; Models, Molecular; Molecular Structure; Peroxisome Proliferator-Activated Receptors; Structure-Activity Relationship

2013
Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages.
    FEBS letters, 2001, May-04, Volume: 496, Issue:1

    Topics: Animals; Apigenin; Binding, Competitive; Cell Line; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Flavonoids; Genes, Reporter; Kaempferols; Macrophages; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Protein Binding; Quercetin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors

2001